Intellectual Property Owners Association

Serving the Global Intellectual Property Community


Pharmaceutical & Biotechnology Issues Committee


The Committee will advise the IPO Board of Directors regarding legislative changes, patent office policies, regulatory issues and judicial decisions affecting the pharmaceutical and biotechnology industry. This includes pharmaceuticals subject to the Drug Price Competition and Patent Term Restoration Act (the Hatch-Waxman Act), the Biologics Price Competition and Innovation Act (the BPCIA Act), and non-U.S. counterpart laws and regulations. The committee will identify amicus opportunities in the U.S., Europe, and elsewhere on key matters impacting the pharmaceutical and biotechnology industry. The committee’s primary goal is to review proposed legislative and regulatory initiatives and proactively submit comments and recommendations to the Board that reflect the proper balance between generic drug/biosimilar entry and maintaining strong incentives for the discovery, development and protection of new pharmaceutical products. A secondary goal of the committee is to monitor and comment upon judicial decisions and proposed patent practice changes for the education and benefit of IPO members.

Committee Roster

Chair: Paul Golian, Bristol-Myers Squibb Company
Vice Chair: Grantland G. Drutchas, McDonnell Boehnen Hulbert & Berghoff LLP
Vice Chair: John M. Griem, Jr., Carter Ledyard & Milburn LLP
Secretary: Kathryn Wade, Kilpatrick Townsend & Stockton LLP
Board Liaison: Don Michael Young, Roche, Inc.
Staff Liaison: Samantha J. Aguayo, Intellectual Property Owners Association


 Timothy J. Babcock
 Akros Pharma Inc.

 Aaron F. Barkoff
 McAndrews, Held & Malloy, Ltd.

 Bryan Beel
 Perkins Coie, LLP

 Nicole M. Beeler
 Merck & Co Inc.

 Ravi Bhola
 K & S Partners

 Caryn C. Borg-Breen
 Green Griffith Borg-Breen LLP

 William Boudreaux
 Brinks Gilson & Lione

 Paul Calvo
 Sterne, Kessler, Goldstein & Fox, PLLC

 Cindy Chang
 Alston & Bird LLP

 Garreth Andrew Duncan
 D Young & Co LLP

 Cassie J. Edgar
 ABS Global, Inc.

 Rachel J. Elsby
 Akin Gump Strauss Hauer & Feld LLP

 Kent Fagan
 Thompson Hine LLP

 Therese Finan
 Dinsmore & Shohl LLP

 Tasha Francis
 Fish & Richardson, PC

 Michael L. Fuller
 Knobbe, Martens, Olson & Bear, LLP

 David A. Gass
 Marshall, Gerstein & Borun LLP

 Maximilienne Giannelli
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

 Linda Govenlock

 Timothy E. Grimsrud
 Faegre Baker Daniels LLP

 Tom Gumley
 FPA Patent Attorneys Pty Ltd

 Sana Halwani
 Lenczner Slaght

 Bo Han
 Bristol-Myers Squibb Company

 Elisabeth R. Healey
 Vorys, Sater, Seymour and Pease LLP

 Erica Hines
 Heslin Rothenberg Farley & Mesiti PC

 Sarah Hooson
 Merck & Co Inc.

 Benjamin H. Hsing

 Andrew E.J. Hutchinson
 Simmons & Simmons LLP

 Thomas L. Irving
 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

 Charlotte Jacobsen
 Ropes & Gray LLP

 Christopher T. Jagoe
 Kirkland & Ellis, LLP

 Andrea Weiss Jeffries
 Jones Day

 Lawrence Kass
 Buchanan Ingersoll & Rooney PC

 Omar Khan
 Wilmer Cutler Pickering Hale and Dorr, LLP

 Nicole Kopinski
 Leydig, Voit & Mayer, Ltd.

 Serge Lapointe
 Fasken Martineau DuMoulin LLP

 Stephanie Adrienne Lodise

 Christopher E. Loh
 Fitzpatrick, Cella, Harper & Scinto

 Tom Malone

 Ryan L. Marshall
 Brinks Gilson & Lione

 Deborah Martin
 Pfizer Inc.

 Vikram A. Mathrani
 Honigman Miller Schwartz and Cohn LLP

 Eileen McMahon
 Torys LLP

 Pamela Mingo
 Bristol-Myers Squibb Company

 Jeff Nichols
 Brinks Gilson & Lione

 Liliana Nolan
 Mersan, Abogados

 Keith Orso
 Irell & Manella LLP

 Caroline Ya-Lan Pao
 Jianq Chyun IP Office

 Heather Petruzzi
 Wilmer Cutler Pickering Hale and Dorr, LLP

 Xavier Pillai
 Leydig, Voit & Mayer, Ltd.

 Louisa Pontrelli
 Norton Rose Fulbright

 Filko Prugo
 Ropes & Gray LLP

 Leanne Rakers
 Harness, Dickey & Pierce, P.L.C.

 Preston K. Ratliff
 Paul Hastings LLP

 Irena Royzman
 Patterson Belknap Webb & Tyler LLP

 Hari Santhanam
 Kirkland & Ellis, LLP

 Hassen Sayeed
 O'Melveny & Myers LLP

 Michael Schubert
 Leydig, Voit & Mayer, Ltd.

 Raj Shah
 Johnson & Johnson

 Patricia A. Shatynski
 Merck & Co Inc.

 Teige Sheehan
 Heslin Rothenberg Farley & Mesiti PC

 Vincent K. Shier

 Brian Shortell
 Ballard Spahr LLP

 Kitt Sinden
 Aird & McBurney LP

 Stephany Small
 Buchanan Ingersoll & Rooney PC

 Lauren Stevens
 Dennemeyer & Associates S.A.

 Thomas Thrash
 Vorys, Sater, Seymour and Pease LLP

 Amrish Tiwari
 K & S Partners

 Adrian Trioli
 Adrian M Trioli Patent & Trademark Attorney

 Dana Weir
 Paul Hastings LLP

 Jeffrey A. Wolfson
 Haynes and Boone, LLP

 George C. Yu
 Schiff Hardin LLP

 Richard Zanzalari
 Pfizer Inc.

 Donald L. Zuhn
 McDonnell Boehnen Hulbert & Berghoff LLP


Non-Voting Member:Courtenay C. Brinckerhoff, Foley & Lardner LLP
Non-Voting Member:Julie Burke, Knobbe, Martens, Olson & Bear, LLP
Non-Voting Member:Robert Burrows, Bristows LLP
Non-Voting Member:Carlyn Burton, Osha Liang, LLP
Non-Voting Member:Janet Cord, Ladas & Parry LLP
Non-Voting Member:Kathy Coulter, Bristol-Myers Squibb Company
Non-Voting Member:Dianne Elderkin, Akin Gump Strauss Hauer & Feld LLP
Non-Voting Member:Serena I. Farquharson-Torres, Bristol-Myers Squibb Company
Non-Voting Member:Emily Johnson, Amgen, Inc.
Non-Voting Member:Robert J. Kajubi, Sanofi
Non-Voting Member:Richard Kurz, Haug Partners LLP
Non-Voting Member:Stacy Lewis, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Non-Voting Member:Toby Mak, Tee & Howe Intellectual Property Attorneys
Non-Voting Member:Mercedes K. Meyer, Drinker, Biddle & Reath, LLP
Non-Voting Member:Brian P. Murphy, Haug Partners LLP
Non-Voting Member:Corey Salsberg, Novartis
Non-Voting Member:Andrew Skodyn, Lenczner Slaght
Non-Voting Member:J. Eric Thies, Merck & Co Inc.
Non-Voting Member:Deepa Kachroo Tiku, K & S Partners
Non-Voting Member:Holger Carl Tostmann, Wallinger Ricker Schlotter Tostmann
Non-Voting Member:Camille Turner, Haug Partners LLP
Non-Voting Member:Wenwen Wang, Advance China IP Law Office
Non-Voting Member:Andrew W. Williams, McDonnell Boehnen Hulbert & Berghoff LLP
Non-Voting Member:Yingying Zeng, Merck & Co Inc.

If you are an IPO Member, you may login to view committee contact information by clicking here.